Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
May 10, 2024 at 04:11 am EDT
Share
Dr. Lal PathLabs Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 5,454 million compared to INR 4,910 million a year ago. Revenue was INR 5,638 million compared to INR 5,052 million a year ago. Net income was INR 845 million compared to INR 567 million a year ago. Basic earnings per share from continuing operations was INR 10.13 compared to INR 6.84 a year ago. Diluted earnings per share from continuing operations was INR 10.12 compared to INR 6.82 a year ago.
For the full year, sales was INR 22,266 million compared to INR 20,169 million a year ago. Revenue was INR 22,958 million compared to INR 20,586 million a year ago. Net income was INR 3,577 million compared to INR 2,389 million a year ago. Basic earnings per share from continuing operations was INR 43.05 compared to INR 28.82 a year ago. Diluted earnings per share from continuing operations was INR 42.98 compared to INR 28.74 a year ago.
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.